These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 8438452)

  • 21. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.
    Gracida C; Melchor JL
    Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318
    [No Abstract]   [Full Text] [Related]  

  • 23. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H; Wu J; Luo H; Daloze P
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract]   [Full Text] [Related]  

  • 25. Triple therapy with cyclosporine A in kidney transplant patients.
    Matl I; Jirka J; Petrásek R; Vítko S
    Transplant Proc; 1995 Oct; 27(5):2573. PubMed ID: 7482831
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapamycin in experimental renal allografts in dogs and pigs.
    Collier DS; Calne R; Thiru S; Lim S; Pollard SG; Barron P; Da Costa M; White DJ
    Transplant Proc; 1990 Aug; 22(4):1674-5. PubMed ID: 2143858
    [No Abstract]   [Full Text] [Related]  

  • 27. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
    Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
    Opelz G
    Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 30. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 32. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
    Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 37. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A; Plenter R; Francis DM; Clunie GJ
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract]   [Full Text] [Related]  

  • 38. Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation.
    Ochiai T; Gunji Y; Nagata M; Asano T; Isono K
    Transplant Proc; 1991 Dec; 23(6):2718-9. PubMed ID: 1721255
    [No Abstract]   [Full Text] [Related]  

  • 39. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
    Kahan BD
    Transplant Proc; 1995 Feb; 27(1):33-6. PubMed ID: 7879019
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
    Thompson P; Xu D; Brunette I; Chen H
    Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.